Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
J Neuroimmunol
; 361: 577755, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: covidwho-1472063
ABSTRACT
Vaccine administration may be involved in the development of some central nervous system demyelinating diseases. The COVID-19 vaccine is being administered to the entire population, but to date, little association between vaccination and the risk of developing multiple sclerosis (MS) has been suggested, and only a few case reports have been published. Here, we present a 40-year-old woman who developed cervical myelitis after receiving the COVID-19 vaccine. Myelitis was considered the initial clinical manifestation of MS. Our case suggests a possible link between the vaccination and the clinical MS attack.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Vacina BNT162
/
Esclerose Múltipla
Tipo de estudo:
Relato de caso
/
Estudo observacional
/
Estudo prognóstico
Tópicos:
Covid persistente
/
Vacinas
Limite:
Adulto
/
Feminino
/
Humanos
Idioma:
Inglês
Revista:
J Neuroimmunol
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS